Medical experts discuss how the Inflation Reduction Act’s out-of-pocket prescription drug cost cap, effective in 2025, may impact access to oral chemotherapy options for metastatic colorectal cancer.
Jul. 2—MORGANTOWN — With the ever-changing landscape of high school athletics in the state of West Virginia, some decisions need to be made with the thought of the present and future of a program in ...
Michael S. Leapman, MD, MHS, is associate professor of urology and clinical program leader of the prostate and urologic cancers program at Yale School of Medicine.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results